drugset / Trial / NCT01292161

Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C

NCT01292161

Phase 2 Completed 55 enrolled Isfahan University of Medical Sciences
NaSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the effects of silymarin on outcomes of patients with hepatitis C.

Timeline

Start
2006-03
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Silymarin Traditional medicine (herbal / TCM) 630 mg